{‘She has little qualifications’: this American scientific establishment girds for Tracy Beth Høeg’s role at the FDA.

Given that the US undertakes unprecedented changes to its immunization schedules, a particular individual has emerged somewhat surprisingly: Tracy Beth Høeg, an American of Danish descent sports medicine doctor and epidemiologist who first made her name by expressing skepticism about coronavirus shots during the pandemic and has concentrated on alleged deaths following Covid immunization in her brief time at the Food and Drug Administration.

Scheduled Overhauls to Childhood Vaccine Schedule

Agency leaders were set to reveal radical revisions to the pediatric vaccination calendar earlier this month, bringing the US with the Danish immunization schedule, it is understood – a substantial departure that would place the US at odds with much of the global community with no evidence for public health gain. The planned update has been delayed until the coming year.

Rather than Vinay Prasad, Dr. Høeg is scheduled to address the audience at the event. She was recently named temporary leader of the FDA’s CDER, the fifth individual to run the office this year.

A New Direction at the Regulatory Body

The acting appointment may indicate a closer partnership between the pharmaceutical and vaccine divisions as Dr. Høeg and Dr. Prasad solidify control at the FDA – and it suggests a greater focus upon reevaluating already-approved vaccines at the FDA.

Dr. Høeg has often pushed for halting some childhood immunization guidelines in the US to become more similar to Denmark, a nation with comprehensive healthcare and a number of inhabitants about the size of Wisconsin’s.

To date statements, she has persisted in emphasizing on vaccination policy – usually the domain of Prasad, head of the FDA’s CBER – rather than pharmaceutical oversight.

Doubts Over Expertise

The appointee has little discernible background in medication creation, approval processes or management, which has been typical for former leaders of the biologics center. She has been employed at the FDA as a top consultant to the FDA chief and the vaccine center since spring.

“She doesn’t seem to have the requisite experience” for leading the CDER, stated Jonathan Howard. “She’s never run a scientific study. She is not versed in leading a large organization. She is not an expert in industry regulation.”

Previous heads of the center would “be deeply familiar with legal statutes and the science of drug development”, commented Janet Woodcock. “Frankly, she lacks the type of experience that prior appointees who headed the center have had.”

This division has an enormous range of responsibilities at the agency, the former commissioner stated.

“The public just focuses on the novel medication approvals, but the generic program authorizes numerous off-brand pharmaceuticals. There’s a biosimilars program, over-the-counter program and more, and each of these need to be looked after,” Woodcock noted. “The area you neglect, that is precisely what that I always told people is going to bite you.”

Additionally, a substantial administrative aspect to the role, which oversees in excess of 5,000 staff members. “It’s a enormous leadership role, if you do it right,” Woodcock concluded.

Official Statement and Contentious Policies

When asked about questions about Dr. Høeg's fitness for the role and whether this assignment represents more teamwork among regulatory chiefs on vaccines, a spokesperson said that the “inquiries rely on incorrect presumptions”.

“Her experience matches the responsibilities of her position,” the official explained, pointing to the months Høeg spent advising the FDA commissioner on “drug safety and regulatory science, including computational safety modeling and immunization monitoring”.

In her interim role, Høeg inherits the commissioner’s controversial priority voucher program, a disputed rapid medication authorization process that apparently concerned her former heads. “How are these medications being picked for this expedited pathway? Who takes the decisions?” Howard asked. “There’s a lot of secrecy happening at the FDA right now.”

Broadly speaking, he stated, “the Food and Drug Administration appears to be shifting towards more relaxed rules of all drugs, except for shots.”

Documented History on Vaccines

Concerning vaccines, Høeg has a more documented, if troubling, track record, critics said. She published a research paper using unverified public submissions to estimate the incidence of myocarditis following Covid vaccination. She consulted for the state of Florida top health official Dr. Joseph Ladapo, who allegedly have changed statistics to imply Covid vaccines are more dangerous than they are.

Included in her “wish list” for the current government featured changing rules for recently developed shots and ending “unnecessary” vaccines, she stated post-election on a podcast. At the agency, Høeg has allegedly suggested barring young men from getting Covid vaccinations.

“She is an thorough dogmatist who begins with her beliefs and works backwards to fit the evidence in a highly disingenuous, fraudulent way,” Dr. Howard stated.

Taking Control and a “Revenge Tour”

Dr. Høeg joined fellow dissenters, {like|